drugset / Trial / NCT00139152
Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to study the effects of Xolair using non-invasive techniques from the expired gas of patients with moderate to severe allergic asthma.
Timeline
- Start
- 2005-09
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omalizumab | Monoclonal antibody | 0.016 mg/kg | Subcutaneous |